HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Victor In China’s Cosmetic-Ingredient Approval Process Tells His Story

This article was originally published in The Rose Sheet

Executive Summary

Navigating China’s notoriously challenging registration process for new cosmetic ingredients requires a local representative who can respond quickly to CFDA’s questions before the evaluation committee membership changes and sends firms back to square one. A former Symrise exec offers insight into the process and how the supplier successfully won approval for its SymWhite 377 brightening agent.

You may also be interested in...



China’s Cosmetic Animal-Testing Exemption 'Not Yet A Terribly Meaningful Solution' – PCPC

The Personal Care Products Council’s Francine Lamoriello, EVP of global strategies, discusses shortcomings of a proposed animal-testing exemption for imported general cosmetics under a key implementing regulation drafted for China’s new cosmetics oversight framework.

PCPC Expects Rapid-Fire Implementing Measures Following China’s CSAR Drop

China’s newly adopted Cosmetics Supervision and Administration Regulation could mean less animal testing and speedier approval of new ingredients, according to Francine Lamoriello of the Personal Care Products Council. Coming implementing regulations, standards and guidances should help to provide needed clarity, she says.

China On Verge Of Large-Scale Cosmetics Reg Reforms – PCPC Exec

The Personal Care Products Council’s head of global strategies says a revised cosmetics framework law could be enacted in China in the 2019 first quarter. It’s expected to shift China to a more risk-based system, reducing bureaucratic red tape and promoting fairer competition, though some of the finer details will depend on implementing regulations.

Related Content

Topics

UsernamePublicRestriction

Register

PS142351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel